To free the 16 million people with Type 1 Diabetes from daily insulin injections and diabetes associated complications without relying on potentially harmful anti-rejection drugs that compromise their quality of life.

Next Generation Therapy for Diabetes

Curing type 1 diabetes without immuno-suppressive agents.

Click here to learn more about the science behind SymbioCellTech's “Neo-Islet” technology